Milan, Italy

Roberto Sacilotto

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roberto Sacilotto

Introduction

Roberto Sacilotto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with unique therapeutic properties. His work has led to the creation of a patent that showcases his innovative approach to drug formulation.

Latest Patents

Roberto Sacilotto holds a patent for "Methyllevallorphanium salts having peripheral opiate antagonistic activity." This patent describes a process for preparing methyllevallorphanium salts, which have potential applications in pharmaceutical compositions. The invention focuses on the use of anions from pharmaceutically acceptable acids, excluding halogens, to enhance the therapeutic efficacy of these compounds.

Career Highlights

Roberto is currently employed at Sanofi, a leading global healthcare company. His role involves research and development, where he applies his expertise to create innovative pharmaceutical solutions. His dedication to advancing medical science is evident in his work and the impact it has on patient care.

Collaborations

Throughout his career, Roberto has collaborated with esteemed colleagues, including Alberto Bianchetti and Dino Nisato. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the innovation process.

Conclusion

Roberto Sacilotto's contributions to the field of pharmaceuticals exemplify the spirit of innovation. His patent for methyllevallorphanium salts highlights his commitment to developing new therapeutic options. Through his work at Sanofi and collaborations with fellow researchers, he continues to make strides in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…